TP53 and breast cancer: This state transition largely attributes to functional antitumor inactivation and oncogenicity transformation of p53.[209] Similarly, the p53 R248Q mutant, the most common mutant found in breast cancers and is ranked among the strongest predictors of poor outcomes in ovarian cancer, forms mesoscopic protein‐rich clusters in cancer cells.